Robert A. Eckert is our lead independent director. Mr. Eckert has been an Operating Partner at FFL Partners, LLC (formerly known as Friedman Fleischer & Lowe, LLP), a private equity firm, since 2014. Mr. Eckert was the Chief Executive Officer of Mattel, Inc., a toy design, manufacture and marketing company, having held this position from 2000 through 2011, and its Chairman of the Board from 2000 through 2012. He was President and Chief Executive Officer of Kraft Foods Inc., a consumer packaged food and beverage company, from 1997 to 2000, Group Vice President from 1995 to 1997, President of the Oscar Mayer Foods Division from 1993 to 1995 and held various other senior executive and other positions from 1977 to 1992.
Mr. Eckert has been a director of McDonald’s Corporation, a company that franchises and operates McDonald’s restaurants in the global restaurant industry, since 2003, serving as the Chair of the Public Policy and Strategy Committee and a member of the Executive and Governance Committees. Mr. Eckert also has served as a director of Levi Strauss & Co., a jeans and casual wear manufacturer, since 2010, serving as Chair of the Nominating, Governance and Corporate Citizenship Committee and a member of the Compensation Committee and, since March 2021, as non-executive Chair of the board. In 2020, Mr. Eckert was appointed a director of Uber Technologies, Inc., a personal mobility, meal delivery and logistics technology platform, serving as Chair of the Compensation Committee and a member of the Nominating and Governance Committee. Mr. Eckert was a director of Smart & Final Stores, Inc., a warehouse store, from 2013 until 2014 prior to it becoming a publicly-traded company. He was appointed director of Eyemart Express Holdings LLC, a privately-held eyewear retailer and portfolio company of FFL Partners, LLC, in 2015. Mr. Eckert is on the Global Advisory Board of the Kellogg School of Management at Northwestern University and serves on the Eller College National Board of Advisors at the University of Arizona. Mr. Eckert received an undergraduate degree from the University of Arizona and a master’s degree in business administration from the Kellogg School of Management at Northwestern University.
What is Robert Eckert's net worth?
The estimated net worth of Robert Eckert is at least $6.66 million as of August 18th, 2022. Mr. Eckert owns 21,184 shares of Amgen stock worth more than $6,661,754 as of March 24th. This net worth approximation does not reflect any other assets that Mr. Eckert may own. Learn More about Robert Eckert's net worth.
How do I contact Robert Eckert?
The corporate mailing address for Mr. Eckert and other Amgen executives is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. Amgen can also be reached via phone at (805) 447-1000 and via email at investor.relations@amgen.com. Learn More on Robert Eckert's contact information.
Has Robert Eckert been buying or selling shares of Amgen?
Robert Eckert has not been actively trading shares of Amgen during the last ninety days. Most recently, Robert Eckert sold 6,600 shares of the business's stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $249.00, for a transaction totalling $1,643,400.00. Following the completion of the sale, the director now directly owns 21,184 shares of the company's stock, valued at $5,274,816. Learn More on Robert Eckert's trading history.
Who are Amgen's active insiders?
Amgen's insider roster includes Robert Bradway (Chairman & Chief Executive Officer), Robert Eckert (Director), Murdo Gordon (EVP), Jonathan Graham (EVP), Peter Griffith (Exec. VP & CFO ), Nancy Grygiel (SVP), Nancy Grygiel (SVP), David Reese (Executive Vice President and Chief Technology Officer), Ronald Sugar (Director), Ronald Sugar (Director), and R Williams (Director). Learn More on Amgen's active insiders.
Are insiders buying or selling shares of Amgen?
During the last year, insiders at the medical research company sold shares 6 times. They sold a total of 71,458 shares worth more than $21,307,146.27. The most recent insider tranaction occured on February, 21st when EVP David M Reese sold 25,225 shares worth more than $7,679,499.00. Insiders at Amgen own 0.7% of the company.
Learn More about insider trades at Amgen. Information on this page was last updated on 2/21/2025.
